Lv5
1185 积分 2020-04-20 加入
Development and validation for bioanalysis of VK2809, its active metabolite VK2809A and glutathione-conjugated metabolite MB06588 in rat liver using LC-MS/MS
2天前
已关闭
American Society for Clinical Pharmacology and Therapeutics
2天前
已完结
An oral GLP-1 and GIP dual receptor agonist improves metabolic disorders in high fat-fed mice
7天前
已完结
Coadministration of the long‐acting amylin analog cagrilintide plus semaglutide (CagriSema), resulted in significantly greater weight loss, along with improved measures of glucose control, in a short phase 2 trial of patients with type 2 diabetes
8天前
已完结
Cagrilintide: A Long-Acting Amylin Analog for the Treatment of Obesity
8天前
已完结
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial
8天前
已完结
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial
8天前
已完结
Progress and limitations of oral peptide delivery as a potentially transformative therapy
17天前
已完结
In Vivo Mechanism of Action of Sodium Caprate for Improving the Intestinal Absorption of a GLP1/GIP Coagonist Peptide
21天前
已完结
Characterization and impact of peptide physicochemical properties on oral and subcutaneous delivery
21天前
已完结
